Posted: February 15th, 2023
L.N. is a 49-year-old white woman with a history of type 2 diabetes, obesity, hypertension, and migraine headaches. The patient was diagnosed with type 2 diabetes 9 years ago when she presented with mild polyuria and polydipsia. L.N. is 5′4″ and has always been on the large side, with her weight fluctuating between 165 and 185 lb.
Initial treatment for her diabetes consisted of an oral sulfonylurea with the rapid addition of metformin. Her diabetes has been under fair control with a most recent hemoglobin A1c of 7.4%.
Hypertension was diagnosed 5 years ago when blood pressure (BP) measured in the office was noted to be consistently elevated in the range of 160/90 mmHg on three occasions. L.N. was initially treated with lisinopril, starting at 10 mg daily and increasing to 20 mg daily, yet her BP control has fluctuated.
One year ago, microalbuminuria was detected on an annual urine screen, with 1,943 mg/dl of microalbumin identified on a spot urine sample. L.N. comes into the office today for her usual follow-up visit for diabetes. Physical examination reveals an obese woman with a BP of 154/86 mmHg and a pulse of 78 bpm.
SOLUTION
Based on the information provided, L.N. is a 49-year-old woman with multiple comorbidities, including type 2 diabetes, obesity, hypertension, and migraine headaches. She was diagnosed with diabetes 9 years ago and has been treated with a combination of an oral sulfonylurea and metformin, with fair control of her blood sugar levels (hemoglobin A1c of 7.4%). L.N. has a history of elevated blood pressure, which was diagnosed 5 years ago and has been treated with lisinopril, though her control has been inconsistent.
It is important for L.N. to manage her comorbidities effectively in order to minimize the risk of complications associated with these conditions. For her diabetes, it may be helpful to consider additional medication options, such as GLP-1 receptor agonists or SGLT-2 inhibitors, which have been shown to improve blood sugar control and provide cardiovascular benefits. Weight management strategies may also be helpful, as weight loss has been shown to improve glycemic control and reduce the risk of cardiovascular disease.
In terms of her hypertension, it may be necessary to adjust her medication regimen or consider additional agents to achieve better blood pressure control. Lifestyle modifications, such as reducing salt intake, increasing physical activity, and losing weight, may also be beneficial in improving her blood pressure levels.
It is also important to address L.N.’s migraine headaches, which may be exacerbated by her comorbidities and potentially impact her quality of life. Treatment options for migraines include preventive medications, such as beta blockers or anticonvulsants, as well as acute medications, such as triptans or nonsteroidal anti-inflammatory drugs (NSAIDs).
Overall, a comprehensive approach to managing L.N.’s comorbidities, including medication management, lifestyle modifications, and potentially other treatments such as weight loss and migraine management, will be important in optimizing her health outcomes.
Place an order in 3 easy steps. Takes less than 5 mins.